European healthcare entrepreneurs who want to get an intense, accurate understanding of the US market as it relates to their commercial planning. If you have a passing familiarity with the US healthcare market, this will help you contextualize quite a lot.

Unlike courses that just teach the same endless sprawl (you know the drill: reimbursement overviews that are just acronyms from consultants, legal overviews that are really pitches from law firms, etc), this is designed to help European companies find commercial success in the US.

• European healthcare models value and incentivize things differently, which means that what’s successful in Finland or Germany will have a different value shape and a different business model.

• These value props and models don’t line up with most of traditional US healthcare. Unfortunately, most US organizations don’t realize this because they aren’t familiar with how systems outside of the US work. They try to force US models that either don’t reflect the value prop rewarded in the home market or they guide companies into a long cycle that is expensive and doesn’t ultimately reward a competitive advantage.

This is true around the world, but this course is aligned with models from the UK to Estonia and made compatible with those time zones.

No, in fact, this course is most useful to you 6-12 months before you think you might want to approach the US. The reason being twofold:

1. You’ll learn how to target to your value proposition and economic model (which may not be going to reimbursement first!)—and this will inform any remaining studies and pilots you may be doing in the meantime.

2. This course shows what really happens in the trenches: what gets adopted, how, and why. The US may or may not be your next best economic move. This course will help you determine how to order your market expansion by cost-of-acquisition and opportunity.

No, just come with the willingness to absorb a lot of information quickly, work case studies, ask critical questions, and put the material to work. No knowledge of healthcare systems is assumed.

Of course not. But it will give you a very practical understanding of how the US landscape works and the key information you’ll need to know to make informed commercial decisions. For deep dives, we offer courses you can take quickly in specific areas you feel you need more insight, such as our Pricing and Profit class that reveals the wild way margins work on the other side of reimbursement and value-based contracting. The next step would be to apply to the Boardroom, which is for companies actively scaling into the US.

The course is in four sessions of 1.5 hours—and it’s intense, though as far as we know, we’ve never made anyone actually cry.

Instead of teaching everything you might ever need to know, this is very specific to what’s useful to healthtech entrepreneurs evaluating their commercial opportunities. Basically, we took all the fluff out. No one has time for that.

You can expect to spend about an hour after each session reviewing the material and mentally preparing for the next. We’ll work through real-world case studies and apply information to your own companies, which you’ll discuss with the Venture Atlas Labs team in your private 1:1. How much you put into it is up to you; what you put in is what you get out of it.

It’s $1,200 (about €1.015). We offer group discounts for 3 or more (email through the contact form or to Elizabeth directly). We also offer discount codes to our partners for their companies. You can always email us to check if your trade agency, cluster, science park, or university have partnered for a code.

This course is applicable to everyone in:

• Medtech (medical devices)

• Software / digital health

• Biotech / pharma

Reach out here and we’ll get back to you as soon as possible.